Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC105370424 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927972 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMD8P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WSCD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C3orf30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC146880 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEX3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGOH2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on